Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-08-27 | Jane Moen has been a director since March 2020. Ms. Moen has been President of the Company’s wholly-owned subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare since June 2018, following a remarkable career track record at VasoHealthcare, starting as an Account Manager at the inception of VasoHealthcare in April 2010 and being promoted to Regional Manager in January 2012, Director of Product Business Lines in July 2012 and Vice President of Sales in April 2016. Jane Moen has been in the medical sales industry for over 17 years, having had prior experience with Ledford Medical Sales, Vital Signs, Inc., Pfizer Inc. and Ecolab, Inc. |
| 2022-10-03 | Jane Moen 42 President of VasoHealthcare and Director March, 2020 ... Jane Moen has been a director since March 2020. ... The table below summarizes compensation paid in the year ended December 31, 2021 by the Company to its then directors: ... Jane Moen is not listed in the director compensation table, indicating no separate director compensation. |
| 2024-08-07 | Jane Moen — President of VasoHealthcare, and Director: She has been a director of Vaso since March 2020 and an executive officer of Vaso since November 2022. Ms. Moen has been President of Vaso’s wholly-owned subsidiary Vaso Diagnostics, Inc. d/b/a VasoHealthcare since June 2018 following a remarkable career track record at VasoHealthcare, starting as an Account Manager at the inception of VasoHealthcare in April 2010 and being promoted to Regional Manager in January 2012 and Vice President of Sales in April 2016. |
Data sourced from SEC filings. Last updated: 2025-12-06